发明申请
- 专利标题： Heterocyclic Sulfonamide Derivatives
- 专利标题（中）： 杂环磺酰胺衍生物
-
申请号： US12938583申请日： 2010-11-03
-
公开(公告)号： US20110190334A1公开(公告)日： 2011-08-04
- 发明人: Mark G. Bock , Dinesh Chikkanna , Clive McCarthy , Henrik Moebitz , Chetan Pandit
- 申请人： Mark G. Bock , Dinesh Chikkanna , Clive McCarthy , Henrik Moebitz , Chetan Pandit
- 申请人地址： CH Basel
- 专利权人： NOVARTIS AG
- 当前专利权人： NOVARTIS AG
- 当前专利权人地址： CH Basel
- 优先权： IN2678/CHE/09 20091104
- 主分类号： A61K31/437
- IPC分类号： A61K31/437 ; C07D471/04 ; A61P35/00
摘要：
The present invention relates to compounds of Formula I where R1a, R1b, X, R2a, R2b, W, R3, R4, and R5 are as defined herein as well as pharmaceutically acceptable salts thereof. The compounds have been shown to act as MEK inhibitors which may be useful in the treatment of hyperproliferative diseases, like cancer and inflammation.
公开/授权文献
- US08466289B2 Heterocyclic sulfonamide derivatives 公开/授权日：2013-06-18
信息查询
IPC分类:
